| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/14/2001 | WO2001042205A2 Treatment of inflammatory bowel disease with vitamin d compounds |
| 06/14/2001 | WO2001042204A1 N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof |
| 06/14/2001 | WO2001042194A1 Adamantane derivatives |
| 06/14/2001 | WO2001042193A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/14/2001 | WO2001042192A2 Vla-4 integrin antagonists |
| 06/14/2001 | WO2001042191A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
| 06/14/2001 | WO2001042189A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 06/14/2001 | WO2001042181A1 Benzyl tetralins, formulations and uses thereof |
| 06/14/2001 | WO2001042180A1 Use of hydroxyethers in cosmetic and pharmaceutical preparations |
| 06/14/2001 | WO2001042179A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 06/14/2001 | WO2001041812A2 Amphiphilic polymers and polypeptide conjugates comprising same |
| 06/14/2001 | WO2001041810A2 Nucleic acid delivery system |
| 06/14/2001 | WO2001041808A1 Medicinal compositions for oral use |
| 06/14/2001 | WO2001041807A2 Transmucosal composition containing a phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 06/14/2001 | WO2001041806A1 Ophthalmic compositions |
| 06/14/2001 | WO2001041795A1 An additive for an animal feed |
| 06/14/2001 | WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001041783A1 Methods and compositions for treatment of inflammatory disease |
| 06/14/2001 | WO2001041780A2 Use of an immunosuppressant for increasing an antifugal activity of a lipopeptide |
| 06/14/2001 | WO2001041778A1 Melanin synthesis inhibition compound and composition containing the same |
| 06/14/2001 | WO2001041775A2 Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response |
| 06/14/2001 | WO2001041773A1 Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins |
| 06/14/2001 | WO2001041772A1 Galenical preparations of dapsone and related sulphones, and method of therapeutic and preventative treatment of disease |
| 06/14/2001 | WO2001041771A2 Transdermal system containing acetylsalicylic acid for treatment of migraine |
| 06/14/2001 | WO2001041770A2 Nanoparticulate eplerenone compositions |
| 06/14/2001 | WO2001041769A2 Combination of cyamemazine and an atypical neuroleptic |
| 06/14/2001 | WO2001041768A2 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 06/14/2001 | WO2001041767A1 USE OF α1AR SUBTYPE-SELECTIVE DRUGS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION |
| 06/14/2001 | WO2001041766A1 The combination of a serotonin reuptake inhibitor and irindalone |
| 06/14/2001 | WO2001041765A1 Compositions containing itraconazole with improved bioavailability and narrow intra- and inter-individual variation of its absorption |
| 06/14/2001 | WO2001041764A1 Use of isoquinoline and quinoline containing substances as imidazoline receptor ligands |
| 06/14/2001 | WO2001041763A1 Treatment of addiction disorders |
| 06/14/2001 | WO2001041762A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041761A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041760A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | WO2001041759A1 Methods for modulation of oocyte activation |
| 06/14/2001 | WO2001041758A2 Valnemulin formulation |
| 06/14/2001 | WO2001041757A1 Cyclodextrin-containing pharmaceutical composition |
| 06/14/2001 | WO2001041756A2 Method and composition for treatment of ischemic neuronal reperfusion injury |
| 06/14/2001 | WO2001041755A2 Topical compositions comprising thalidomide for the treatment of inflammatory diseases |
| 06/14/2001 | WO2001041754A2 Inhibitors of collagen-induced platelet aggregation |
| 06/14/2001 | WO2001041753A2 Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds |
| 06/14/2001 | WO2001041752A2 Use of isoform specific inhibitors of cgmp-dependent protein kinase for treatment of pain |
| 06/14/2001 | WO2001041751A2 Phytoestrogens for treating als |
| 06/14/2001 | WO2001041750A2 Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics |
| 06/14/2001 | WO2001041749A2 Combinations of sumatriptan or naratriptan with cyclooxygenase iiinhibitor |
| 06/14/2001 | WO2001041748A2 Pharmaceutical combinations and their use in treating gastrointestinal disorders |
| 06/14/2001 | WO2001041747A2 Pharmaceutical preparation containing cytostatic agents and electron acceptors for treating cancer |
| 06/14/2001 | WO2001041744A1 Chronotherapeutic diltiazem formulations and the administration thereof |
| 06/14/2001 | WO2001041743A1 New (aminopropyl)methylphosphinic acids |
| 06/14/2001 | WO2001041742A2 Antiviral medication |
| 06/14/2001 | WO2001041734A2 Stable galenic preparations comprising a benzimidazol and method for the production thereof |
| 06/14/2001 | WO2001041733A2 Compressed tablet composition comprising a nsaid |
| 06/14/2001 | WO2001041715A2 Ultraviolet radiation absorbing waxes useful in cosmetic compositions |
| 06/14/2001 | WO2001041707A2 Modulation of in vivo glutamine and glycine levels in the treatment of autism |
| 06/14/2001 | WO2001041705A2 Novel methods for the treatment and prevention of dizziness and pruritus |
| 06/14/2001 | WO2001041704A2 Method for the prevention and/or treatment of atherosclerosis |
| 06/14/2001 | WO2001041702A2 Zinc thiosalicylate, dermatological compositions containing same, in particular in the form of a self-adhesive device and method for preparing same |
| 06/14/2001 | WO2001041701A2 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 06/14/2001 | WO2001041573A1 Therapeutic antimicrobial compositions |
| 06/14/2001 | WO2001041567A1 Deep penetrating antimicrobial compositions |
| 06/14/2001 | WO2001041550A2 Topical anesthetic formulation |
| 06/14/2001 | WO2001041536A2 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001041535A2 Eplerenone crystalline form |
| 06/14/2001 | WO2001028552A3 Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 06/14/2001 | WO2001028537A3 Bissulfonamide derivatives as enzyme inhibitors |
| 06/14/2001 | WO2001027111A3 Bicyclic imidazo-3-yl-amine derivatives |
| 06/14/2001 | WO2001027101A3 Anhydrous salt |
| 06/14/2001 | WO2001019354A3 Composition for ivf |
| 06/14/2001 | WO2001018040A3 Use of leptin in inhibition of endothelial cell proliferation |
| 06/14/2001 | WO2001017989A3 Heteroaryloxypropanolamines as beta3-adrenergic receptor agonists |
| 06/14/2001 | WO2001016133A3 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
| 06/14/2001 | WO2001013904A3 Composition comprising a tramadol material and an anticonvulsant drug |
| 06/14/2001 | WO2001012128A3 Antibacterial agents for the treatment of acute mucosal infections |
| 06/14/2001 | WO2001011933A3 Pharmaceutical compositions comprising a 7-(2-aminoethyl)-benzothiazolone and a pde4 inhibitor |
| 06/14/2001 | WO2001009189A3 Compositions and methods for the treatment of tumors |
| 06/14/2001 | WO2001009113A3 Heterocyclic compounds inhibiting angiogenesis |
| 06/14/2001 | WO2001008632A3 Colloidal composition for esthetic correction |
| 06/14/2001 | WO2001007022A3 Azetidine compounds in cns and eye diseases |
| 06/14/2001 | WO2001005773A8 Conjugates of sodium channel blockers and methods of using the same |
| 06/14/2001 | WO2001002373A8 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 06/14/2001 | WO2000068413A8 Halo- or hydroxy-substituted nocathiacin antibiotics |
| 06/14/2001 | WO2000064441A3 Compound for use as a medicament for treatment of disorders involving bronchocontraction |
| 06/14/2001 | WO2000063219A8 Platinum complexes for the treatment of cancer |
| 06/14/2001 | WO1999067250A8 Syntheses of a variety of lamellarin compounds and analogues |
| 06/14/2001 | WO1998033528A9 Induction of b cell tolerance |
| 06/14/2001 | US20010003782 Novel sterol derivatives used for regulating the meiosis in oocytes and in male germ cells |
| 06/14/2001 | US20010003780 Retinoid antagonists and uses thereof |
| 06/14/2001 | US20010003779 Camptothecin analogs and methods of preparation thereof |
| 06/14/2001 | US20010003754 Stable liquid mineral ascorbate compositions and methods of manufacture and use |
| 06/14/2001 | US20010003753 Methods for treatment of inflammatory diseases |
| 06/14/2001 | US20010003752 Crystalline form of 4- [ 5-methyl-3-phenylisoxazol-4-yl ] benzenesulfonamide |
| 06/14/2001 | US20010003751 Pharmaceutical composition for treating transient ischemic attack |
| 06/14/2001 | US20010003750 Used as research tools in pharmacological, diagnostic studies and treatment of diseases in mammals in which 1L-beta-protease activity is implicated; antiinflammatory agent |
| 06/14/2001 | US20010003749 Arylpiperazines having activity at the serotonin 1A receptor |
| 06/14/2001 | US20010003748 Cycloalky or heterocyclic substituted phenethyl-thiourea compounds used as inhibitor of reverse transcriptase and effective agents for HIV infection treatment, including mutant, drug sensitive or drug resistant strains of HIV |
| 06/14/2001 | US20010003747 Useful in treating or in preventing melatoninergic disorders |
| 06/14/2001 | US20010003746 Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof |
| 06/14/2001 | US20010003745 Administration to a patient suffering from a disease involving bone resorption an effective amount of bisphosphonic acid or salt such as aldendronate and an agent that binds to the androgen receptor which is testosterone |
| 06/14/2001 | US20010003744 Therapeutic compounds |